Detalhe da pesquisa
1.
Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.
J Immunol
; 184(1): 45-55, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19949110
2.
Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial.
PLoS One
; 14(12): e0226320, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31846475
3.
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection.
J Immunother
; 40(2): 62-70, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28166181
4.
An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1.
Hum Vaccin Immunother
; 12(12): 3079-3088, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27580249
5.
A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice.
PLoS One
; 8(10): e76407, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24098493
6.
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
J Virol
; 80(8): 3975-84, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16571814
7.
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice.
J Virol
; 80(13): 6318-23, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16775319
8.
Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.
Vaccine
; 21(21-22): 2692-7, 2003 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12798605